Results 11 to 20 of about 10,913 (208)
Methimazole-Induced Pleural Effusion in the Setting of Graves’ Disease
Case Reports in Endocrinology, 2019 Methimazole is a thionamide drug that inhibits the synthesis of thyroid hormones by blocking the oxidation of iodine in the thyroid gland. We report a case of methimazole-induced recurrent pleural effusion.
Le Yu Khine +5 more
doaj +2 more sources
The Role of Endoplasmic Reticulum Stress in Cell Injury Induced by Methimazole on Pancreatic Cells [PDF]
Advanced Pharmaceutical Bulletin, 2023 Purpose: Methimazole is an anti-thyroid agent, especially as main therapy option for Graves’ disease in children and adults. Drug induced pancreatitis is one of the known adverse effect of methimazole mentioned in case reports.
Özge Yazıcı +3 more
doaj +3 more sources
Two Cases of Methimazole-Induced Insulin Autoimmune Syndrome in Graves' Disease [PDF]
Endocrinology and Metabolism, 2013 We report here the cases of two females with Graves' disease who developed insulin autoimmune syndrome after treatment with methimazole. The patients exhibited a sudden altered mental state after treatment with methimazole for approximately 4 weeks ...
Eun Roh +9 more
doaj +2 more sources
Methimazole Associated Neutropenia in a Preterm Neonate Treated for Hyperthyroidism [PDF]
Case Reports in Endocrinology, 2015 Maternal Graves’ disease is relatively uncommon with an estimated incidence of 0.4%–1% of all pregnancies, but only 1–5% of newborns delivered to mothers with Graves’ disease develop overt clinical signs and symptoms of hyperthyroidism. Here, we describe
Dimitrios Angelis +2 more
doaj +2 more sources
Cholestasis and Acute Cholecystitis in Hyperthyroidism Treated With Methimazole
International Journal of Gerontology, 2009 Hepatic dysfunction and jaundice are usually present in patients with hyperthyroidism. It may be the clinical manifestation of the disease or the adverse effect of antithyroid therapy.
Wei-Che Chen +3 more
doaj +2 more sources
From antithyroid therapy to oral necrosis: oral manifestations of methimazole-induced agranulocytosis: a case report [PDF]
Journal of Medical Case ReportsBackground Methimazole is a widely used antithyroid medication with a well-documented risk of hematological adverse effects, particularly agranulocytosis.
Haitham Medhioub +5 more
doaj +2 more sources
A case of severe erythema nodosum induced by methimazole
Saudi Pharmaceutical Journal, 2017 Erythema nodosum (EN), is the most common variant of septal panniculitis and is possibly a delayed hypersensitivity reaction triggered by a wide range of antigenic stimuli.
Selma Emre +4 more
doaj +2 more sources
F1000ResearchA 56-year-old female with a medical history of unspecified hyperthyroidism and a recent thyroid storm presented to the ED with tachycardia, hypertension, and bilateral enlarged parotid glands.
Ricky Rana +3 more
doaj +2 more sources
Journal of Ardabil University of Medical Sciences, 2015 Backgrounds & objectives: In addition to their genomic actions, thyroid hormones (THs) can modulate the immune responses through cell surface receptors. One of these is the antiviral effect of THs. Methimazole, as an anti-thyroid compound, is widely used
Hadi Feizi +3 more
doaj +1 more source